Drugs / Desflurane
last change 11 days ago re-read 9 days ago

Desflurane

Other / unclassified targets CDC42, CLOCK, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9 via activation

Developed for
delirium · coronary artery disorder · aortic valve stenosis · cognitive disorder · ischemic disease · pediatric acute respiratory distress syndrome · subjective cognitive decline · acute lung injury
+1 more · non-small cell lung carcinoma
Investigated by
Yonsei University · Kangbuk Samsung Hospital · Seoul National University Hospital · Baxter Healthcare Corporation · Beijing Tiantan Hospital · Cantonal Hospital of St. Gallen
+79 more · Medical University of Gdansk · Medical University of Vienna · Ruhr University of Bochum · University of Zurich · Ain Shams University · Ajou University School of Medicine · All India Institute of Medical Sciences · All India Institute of Medical Sciences, Raebareli, UP · Aristotle University Of Thessaloniki · Assistance Publique - Hôpitaux de Paris · Ataturk University · Baskent University Ankara Hospital · Begoña Quintana Villamandos · Beijing Chao Yang Hospital · C. R. Bard · Centre Hospitalier Universitaire Vaudois · Chiang Mai University · Chih-Cheng Hung · Children's Hospital Medical Center, Cincinnati · DongGuk University · Eye & ENT Hospital of Fudan University · Fondation Apicil · Gachon University Gil Medical Center · Gangnam Severance Hospital · Georgia Tsaousi · German Federal Ministry of Education and Research · Harran University · Huazhong University of Science and Technology · Inje University · Insel Gruppe AG, University Hospital Bern · Kantonsspital Münsterlingen · Kantonsspital Winterthur KSW · Keimyung University Dongsan Medical Center · Kocaeli City Hospital · Konkuk University Medical Center · Konya City Hospital · Ludwig-Maximilians - University of Munich · Mahidol University · Malaysian Society of Anaesthesiologists · Medical University Innsbruck · Menoufia University · Mercy Facial Plastic Surgery Center · Muğla Sıtkı Koçman University · Nanjing Medical University · National and Kapodistrian University of Athens · Nobuyuki Katori · Ohio State University · Prince of Songkla University · Pusan National University Yangsan Hospital · RWTH Aachen University · Saint Savvas Anticancer Hospital · Sefako Makgatho Health Sciences University · Shengjing Hospital · Sichuan Provincial People's Hospital · Stony Brook University · Tam Anh Research Institute · Tam Anh TP. Ho Chi Minh General Hospital · The Catholic University of Korea · The Cleveland Clinic · The Second Affiliated Hospital of Chongqing Medical University · Theodor Bilharz Research Institute · Tianjin First Central Hospital · Tokyo Women's Medical University · Trakya University · Triemli Hospital · Ufuk University · Universiti Sains Malaysia · University Hospital Hradec Kralove · University Hospital, Basel, Switzerland · University Hospital, Clermont-Ferrand · University of Malaya · University of Melbourne · Vita-Salute San Raffaele University · West China Hospital · all 85 on the full record

Regulatory milestones approvals, filings & regulatory actions · 2 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansion US (FDA) SUPRANE — 2006-12-15 fda.gov ↗
Approved US (FDA) SUPRANE — 1992-09-18 fda.gov ↗

Trials 94 · started per year

today
US approved 1992
1
2
2
1
2
4
2
5
14
6
11
7
2
3
2
6
4
8
2
8
2
1992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 02 trials
Phase 0 NCT06241131 Mar → Dec 2024 — Sichuan Provincial People's Hospital Unknown No outcome recorded
Phase 0 NCT05246371 Jun → Nov 2021 — Ain Shams University Unknown No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT04771962 Jan 2020 → Dec 2021 — Universiti Sains Malaysia Completed No outcome recorded
Phase 22 trials · 1 met primary
Phase 2 NCT02559297 Aug 2015 → Jun 2017 — Mahidol University Completed Met primary
Phase 2 NCT02036736 Apr 2013 → Dec 2014 — Assistance Publique - Hôpitaux de Paris Completed No outcome recorded
Phase 2/31 trial
Phase 2/3 NCT00762372 Feb → Aug 2008 — Baxter Healthcare Corporation Completed No outcome recorded
Phase 37 trials · 2 met primary
Phase 3 NCT07116733 Oct 2025 → Dec 2028 expected — Xijing Hospital Recruiting No outcome recorded
Phase 3 NCT03618082 Jun 2019 → May 2022 — University Hospital, Clermont-Ferrand Unknown No outcome recorded
Phase 3 NCT02872389 Aug → Dec 2016 — Kangbuk Samsung Hospital Completed No outcome recorded
Phase 3 NCT02830243 Jul → Oct 2016 — Kangbuk Samsung Hospital Completed Met primary
Phase 3 NCT02698514 Feb → Jul 2016 — Kangbuk Samsung Hospital Completed No outcome recorded
Phase 3 NCT02609802 Nov 2015 → Jul 2016 musculoskeletal system disorder Kangbuk Samsung Hospital Completed No outcome recorded
Phase 3 NCT02322502 Feb 2015 → Feb 2016 — RWTH Aachen University Completed Met primary
Phase 425 trials · 3 missed
Phase 4 NCT07123870 Jul → Oct 2025 overdue — Kocaeli City Hospital Recruiting No outcome recorded
Phase 4 NCT06779890 May 2025 → Sep 2026 overdue brain edema Georgia Tsaousi Recruiting No outcome recorded
Phase 4 NCT07359508 Jan 2024 → Jun 2025 — All India Institute of Medical Sciences Completed No outcome recorded
Phase 4 NCT05990790 Sep 2023 → Dec 2027 expected delirium Medical University of Vienna Recruiting No outcome recorded
Phase 4 NCT05783518 Mar → Oct 2023 biliary atresia, pediatric acute respiratory distress syndrome Tianjin First Central Hospital Unknown No outcome recorded
Phase 4 NCT05331027 May 2022 → Jun 2023 delirium Medical University of Vienna Completed No outcome recorded
Phase 4 NCT04541823 May 2021 → Dec 2022 delirium Beijing Chao Yang Hospital Unknown No outcome recorded
Phase 4 NCT03917186 Sep 2017 → Dec 2020 kidney failure Begoña Quintana Villamandos Completed No outcome recorded
Phase 4 NCT03194074 Aug 2017 → Jun 2019 cognitive disorder Eye & ENT Hospital of Fudan University Unknown No outcome recorded
Phase 4 NCT03209193 Jul 2017 → Nov 2019 — Seoul National University Hospital Completed No outcome recorded
Phase not applicable56 trials · 5 met primary · 3 missed
— NCT07511634 Apr → Dec 2026 expected — Pusan National University Yangsan Hospital Not yet recruiting No outcome recorded
— NCT07295158 Mar → Aug 2026 — Konya City Hospital Completed No outcome recorded
— NCT07239479 Dec 2025 → Dec 2026 expected colorectal neoplasm Tam Anh Research Institute Recruiting No outcome recorded
— NCT07271472 Dec 2025 → May 2026 — Ataturk University Completed No outcome recorded
— NCT07016308 Jun → Nov 2025 — Harran University Completed No outcome recorded
— NCT06772558 Feb → May 2025 overdue avascular necrosis, benign prostatic hyperplasia, cholecystitis, coronary artery disorder +1 Xiaguang Duan Not yet recruiting No outcome recorded
— NCT06759623 Jan 2025 → Apr 2026 overdue obesity disorder Medical University of Gdansk Recruiting No outcome recorded
— NCT06252207 Dec 2023 → Mar 2026 — The Cleveland Clinic Withdrawn No outcome recorded Stop: Business
— NCT06123624 Nov 2023 → Aug 2024 spinal cord disorder Ajou University School of Medicine Unknown No outcome recorded
— NCT06207344 Oct 2023 → Dec 2024 — The Second Affiliated Hospital of Chongqing Medical University Unknown No outcome recorded
Comparator or background therapy86 trials
Phase 1/2 NCT01700907 Comparator Aug 2012 → Feb 2013 — Sapporo Medical University Completed No outcome recorded
Phase 2 NCT05502458 Comparator Dec 2020 → Aug 2022 hepatocellular carcinoma Zhejiang Cancer Hospital Completed No outcome recorded
Phase 2 NCT02971254 Comparator Dec 2016 → Jan 2019 Down syndrome Asklepieion Voulas General Hospital Completed No outcome recorded
Phase 2 NCT03727607 Comparator Jan 2016 → Dec 2017 obesity disorder Ostfold Hospital Trust Completed No outcome recorded
Phase 2 NCT01696630 Comparator Oct 2012 → Jul 2014 colorectal cancer Centre Leon Berard Completed No outcome recorded

Evidence & citations 17 cited values

Every value below carries the sentence it was read from. 181 sources stand behind the page.

FieldValueCited text
Known as desflurane “The GAS group will receive one or more volatile anesthetics (sevoflurane, desflurane, or isoflurane) for induction and maintenance of anesthesia during the surgery.” NCT06330038 ↗
181

“During the operation, patients are treated with remifentanil, cisatracurium, and desflurane inhalation at 0.5-1.0 minimum alveolar concentration (MAC).” NCT05550714 ↗

“During maintenance, desflurane 5-7% (MAC 1-1.3) and TCI remifentanil at a Ce of 1.5-3 ng/mL will be administered, targeting a BIS value between 40-60.” NCT07271472 ↗

“if inhalational maintenance of anesthesia is used it will be achieved with sevoflurane 1% to 2% or desflurane 3% to 6% end-tidal concentration” NCT03263117 ↗

“General anesthesia for patients will be inducted and maintained with desflurane inhalation and remifentanil infusion.” NCT04983966 ↗

“Patients will be randomized to Sevoflurane or Desflurane as the single volatile anesthetics for general anesthesia.” NCT04395248 ↗

“Maintenance of general anesthesia with volatile agent (sevoflurane, desflurane, or isoflurane)” NCT03034096 ↗

“Patients undergoing anesthesia for bariatric surgery with desflurane as a volatile agent.” NCT06759623 ↗

“The gas flow rate of Desflurane group is 2 L/min, include 50% O2 and 4~5% Desflurane.” NCT02909413 ↗

“Desflurane , introduced into clinical practice in 1990 as an inhaled anesthetic” NCT07116733 ↗

“Sevoflurane or desflurane for induction and maintenance of anesthesia” NCT04503148 ↗

Show 171 more sources

Known as desflurane (Suprane(R), Baxter Healthcare) “desflurane (Suprane(R), Baxter Healthcare)” NCT02191371 ↗
Known as Desflurano ChEMBL registry synonym — accepted as the source's own label CHEMBL1200733 ↗
Known as I-653 ChEMBL registry synonym — accepted as the source's own label CHEMBL1200733 ↗
Known as Suprane ChEMBL registry synonym — accepted as the source's own label CHEMBL1200733 ↗
Known as Suprane (desflurane, USP) “Suprane (desflurane, USP)” NCT01235143 ↗
Action Activate “Potassium channel subfamily K member 10 opener” CHEMBL1200733 ↗
4

“Potassium channel subfamily K member 18 opener” CHEMBL1200733 ↗

“Potassium channel subfamily K member 2 opener” CHEMBL1200733 ↗

“Potassium channel subfamily K member 3 opener” CHEMBL1200733 ↗

“Potassium channel subfamily K member 9 opener” CHEMBL1200733 ↗

Action Inhibit “The volatile anesthetics such as sevoflurane and desflurane are known to block the muscarinic receptor in different ways.” NCT02096224 ↗
Modality Other / unclassified “Desflurane is the new volatile anesthetic agent” NCT01235143 ↗
Route Inhaled “Inhaled desflurane aiming an alveolar concentration of 4 to 6 per cent.” NCT00219856 ↗
Target CDC42 “by modulating Cdc42 and Clock proteins” NCT06772558 ↗
Target CLOCK “by modulating Cdc42 and Clock proteins” NCT06772558 ↗
Target KCNK10 “Potassium channel subfamily K member 10 opener” CHEMBL1200733 ↗
Target KCNK18 “Potassium channel subfamily K member 18 opener” CHEMBL1200733 ↗
Target KCNK2 “Potassium channel subfamily K member 2 opener” CHEMBL1200733 ↗
Target KCNK3 “Potassium channel subfamily K member 3 opener” CHEMBL1200733 ↗
Target KCNK9 “Potassium channel subfamily K member 9 opener” CHEMBL1200733 ↗